Bausch Health
BHC
$8.71
Share price
1.04%
Change (1 day)
22.33%
Change (1 year)
Categories
Bausch Health is a Canadian company that researches, develops and produces pharmaceuticals and markets patented drugs, generics and non-prescription drugs in the areas of dermatology and ophthalmology.
Bausch Health (BHC) - Total debt
Total debt on the balance sheet as of December 2023 : $22.38 B
According to Bausch Health 's latest financial reports the company's total debt is $22.38 B. A company’s total debt is the sum of all current and non-current debts.
Bausch Health - Total debt on balance sheet (from 2001 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023-12-31 | $22.38 B | 7.81% |
| 2022-12-31 | $20.76 B | -8.33% |
| 2021-12-31 | $22.65 B | -5.31% |
| 2020-12-31 | $23.92 B | -7.61% |
| 2019-12-31 | $25.89 B | 6.54% |
| 2018-12-31 | $24.30 B | -4.48% |
| 2017-12-31 | $25.44 B | -14.75% |
| 2016-12-31 | $29.84 B | -4.04% |
| 2015-12-31 | $31.10 B | 104.16% |
| 2014-12-31 | $15.23 B | -12.34% |
| 2013-12-31 | $17.37 B | 57.62% |
| 2012-12-31 | $11.02 B | 65.78% |
| 2011-12-31 | $6.65 B | 80.18% |
| 2010-12-31 | $3.69 B | 840.99% |
| 2009-12-31 | $0.39 B | 515.83% |
| 2008-12-31 | $63.7 M | |
| 2006-12-31 | $0.41 B | -6.03% |
| 2005-12-31 | $0.43 B | -8.79% |
| 2004-12-31 | $0.47 B | -41.06% |
| 2003-12-31 | $0.81 B | 8.72% |
| 2002-12-31 | $0.74 B | 1519.01% |
| 2001-12-31 | $46.16 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 OPKO Health
OPK | $0.32 B | -98.54% | 🇺🇸 USA |
 Onconova Therapeutics ONTX | N/A | N/A | 🇺🇸 USA |